Ian S Mitchell

4PUBLICATIONS
19CO-AUTHORS
Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 16, 2024
Bleed treatment with eptacog beta (rFVIIa) results in a low incidence of rebleeding in adult and adolescent patients with haemophilia A or B with inhibitors.

Amy Dunn, Yesim Dargaud, Yasmina Abajas

|Oct 06, 2021
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.

Miguel Escobar, James Luck, Yevhenii Averianov

|Sep 29, 2018
The future of bypassing agents for hemophilia with inhibitors in the era of novel agents.

A D Shapiro, I S Mitchell, S Nasr

|Aug 05, 2017
PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding.

M Wang, J B Lawrence, D V Quon

Pageof 1